DE69807578T2 - 5-ht1a und 5-ht1d alpha rezeptorantagonisten - Google Patents

5-ht1a und 5-ht1d alpha rezeptorantagonisten

Info

Publication number
DE69807578T2
DE69807578T2 DE69807578T DE69807578T DE69807578T2 DE 69807578 T2 DE69807578 T2 DE 69807578T2 DE 69807578 T DE69807578 T DE 69807578T DE 69807578 T DE69807578 T DE 69807578T DE 69807578 T2 DE69807578 T2 DE 69807578T2
Authority
DE
Germany
Prior art keywords
ht1d
ht1a
receptor antagonists
alpha receptor
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69807578T
Other languages
English (en)
Other versions
DE69807578D1 (de
Inventor
Vincent Patrick Rocco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69807578D1 publication Critical patent/DE69807578D1/de
Application granted granted Critical
Publication of DE69807578T2 publication Critical patent/DE69807578T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69807578T 1997-05-29 1998-05-27 5-ht1a und 5-ht1d alpha rezeptorantagonisten Expired - Fee Related DE69807578T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4825697P 1997-05-29 1997-05-29

Publications (2)

Publication Number Publication Date
DE69807578D1 DE69807578D1 (de) 2002-10-10
DE69807578T2 true DE69807578T2 (de) 2003-05-22

Family

ID=21953552

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69807578T Expired - Fee Related DE69807578T2 (de) 1997-05-29 1998-05-27 5-ht1a und 5-ht1d alpha rezeptorantagonisten

Country Status (8)

Country Link
EP (1) EP0881224B1 (de)
JP (1) JP2002500668A (de)
AT (1) ATE223416T1 (de)
AU (1) AU7378698A (de)
CA (1) CA2291674A1 (de)
DE (1) DE69807578T2 (de)
ES (1) ES2183289T3 (de)
WO (1) WO1998053823A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031224A (en) * 1976-04-29 1977-06-21 American Hoechst Corporation 1,3-Dihydro-heteroarylspiro (isobenzofuran)s
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
FR2689509B1 (fr) * 1992-04-01 1994-06-03 Adir Nouveaux derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
EP0881224B1 (de) 2002-09-04
ES2183289T3 (es) 2003-03-16
AU7378698A (en) 1998-12-30
CA2291674A1 (en) 1998-12-03
JP2002500668A (ja) 2002-01-08
EP0881224A1 (de) 1998-12-02
DE69807578D1 (de) 2002-10-10
WO1998053823A1 (en) 1998-12-03
ATE223416T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
DE69636801D1 (de) Dioxinoderivate und ihre Verwendung als Dopamine Agonisten
ATE245636T1 (de) Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten
ES2179881T3 (es) Antagonistas de endotelina.
NO20001950D0 (no) Syntese av SAPO-44
DE50000102D1 (de) Pyrogen hergestelltes Aluminiumoxid
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
SE9702773D0 (sv) Novel compounds
ES2138247T3 (es) Composicion y uso.
ES2159749T3 (es) Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas).
DE69600020T2 (de) Wasserfreie kosmetische Zusammensetzungen, welche TiO2 Nanopigmente und verformbare hohle Mikrokugeln enthalten
DE69610316T2 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
DK0978284T3 (da) Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister
NO20010654L (no) Ny anvendelse av taxoidderivater
DE60008353D1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
NO985970D0 (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
DK0406211T3 (da) Fucosidase-inhibitorer
DE60024108D1 (de) Leukotrien rezeptor
ATE223416T1 (de) 5-ht1a und 5-ht1d alpha rezeptorantagonisten
ATE256101T1 (de) Gelbe polymorphe form von 5-amino-2,4,6-triiodo-n,n'-bis(2,3-dihydroxypro yl)-isophthalamid
DE69024524D1 (de) Substituierte Tetrahydroindanderivate und ihre Verwendung als Zwischenprodukte
DE69210229D1 (de) Dihydrochinolin NMDA Antagonisten
DE60236623D1 (de) Amorphe substanz eines tricyclischen triazolobenzazepinderivats
DE69115116D1 (de) Heterocyclische NMDA Antagonisten.
DE9413297U1 (de) Bohrerschaftverlängerung
NO20010655D0 (no) Ny anvendelse av taxoidderivater

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee